| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
2.3 -0.01 (-0%) |
09-21 10:14 |
|
Open: |
2.34 |
Pre close: |
2.31 |
Target:
|
2.85
|
|
High: |
2.34 |
Low: |
2.2764 |
Resistance:
|
2.44
2.80
|
|
Volume: |
16,982 |
Market Cap: |
131M |
Support:
|
1.86
1.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.18
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
2.19 |
Signal(12,26,9): |
0.06  |
|
MA(100): |
2.00 |
Stochastic Oscillator |
%K(14,3):
|
30.28 |
|
MA(250): |
2.05 |
%D(3): |
22.05 |
|
Average Volume(K) |
3-Month: |
31564
|
52-Week |
High:
|
3.75 |
|
10-Days: |
29782 |
Low: |
1.12 |
|
RSI |
RSI(14):
|
59.16 |
Change(%): |
102.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.580 |
Return on Equity (ttm) |
-58.3 |
Shares Out. (M) |
56.85 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-42.8 |
Shares Float (M) |
54.02 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.04 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
46.80 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1073 |
|
Book Value (p.s.) |
2.650 |
EBITDA (p.s.) |
-0.115 |
P/E |
-3.98 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.91 |
P/S |
1094362496.00 |
|
Operating Margin |
-541.92 |
Levered Free Cash Flow
(M) |
-19.29 |
P/CF |
-5.49 |
|
|
|
|
|
|
